A/DT
microtitre/NN
assay/NN
system/NN
for/IN
glucocorticoid/NN
receptors/NNS
:/:
decreased/VBN
receptor/NN
concentration/NN
in/IN
myocardial/JJ
infarction/NN
./.

A/DT
major/JJ
difficulty/NN
in/IN
determination/NN
of/IN
glucocorticoid/NN
receptor/NN
sites/NNS
is/VBZ
the/DT
very/RB
complicated/JJ
assay/NN
procedure/NN
./.
=====
Therefore/RB
,/,
we/PRP
describe/VBP
a/DT
microtitre/NN
assay/NN
system/NN
for/IN
glucocorticoid/NN
receptors/NNS
which/WDT
is/VBZ
a/DT
whole-cell/JJ
competitive/JJ
binding/NN
radioassay/NN
using/VBG
[3H]-dexamethasone/NN
as/IN
radioligand/NN
./.
=====
This/DT
modification/NN
of/IN
a/DT
previously/RB
described/VBN
protocol/NN
simplifies/VBZ
and/CC
reduces/VBZ
laboratory/NN
work/NN
and/CC
allows/VBZ
assay/NN
reproducibility/NN
to/TO
be/VB
controlled/VBN
more/RBR
reliably/RB
./.
=====
Thus/RB
enabled/VBN
to/TO
perform/VB
the/DT
test/NN
on/IN
multiple/JJ
blood/NN
samples/NNS
in/IN
parallel/NN
,/,
we/PRP
investigated/VBD
cardiac/JJ
infarction/NN
patients/NNS
over/IN
a/DT
12-day/JJ
period/NN
to/TO
test/VB
if/IN
glucocorticoid/NN
receptor/NN
binding/NN
is/VBZ
altered/VBN
in/IN
this/DT
'/``
stressful/JJ
'/''
disease/NN
./.
=====
On/IN
the/DT
first/JJ
day/NN
of/IN
the/DT
disease/NN
,/,
glucocorticoid/NN
receptor/NN
capacity/NN
was/VBD
significantly/RB
decreased/VBN
without/IN
alteration/NN
of/IN
the/DT
receptor-ligand/JJ
affinity/NN
,/,
whereas/IN
on/IN
days/NNS
4/CD
and/CC
12/CD
the/DT
number/NN
of/IN
receptor/NN
sites/NNS
was/VBD
normal/JJ
again/RB
./.
=====
This/DT
result/NN
fits/VBZ
well/RB
into/IN
the/DT
general/JJ
observation/NN
of/IN
stress-induced/JJ
down-regulation/NN
of/IN
immune/JJ
responses/NNS
./.